SANGAMO THERAPEUTI revenue breakdown overview

SANGAMO THERAPEUTI revenue for the last year amounted to 148.38 M CHF, the most of which — 148.38 M CHF — came from its highest performing source at the moment, Zinc Finger Protein, the year earlier bringing 102.92 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought SANGAMO THERAPEUTI 148.38 M CHF, and the year before that — 102.92 M CHF.